CD40 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD40 monoclonal antibodies for investigating CD40's role in immune response and cell signaling. CD40 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD40 is a crucial co-stimulatory molecule found on the surface of B cells and other immune cells, playing a significant role in the activation and regulation of immune responses. CD40 drives B cell proliferation, differentiation, and antibody production, making it a key player in adaptive immunity. Dysregulation of CD40 signaling has been implicated in various autoimmune diseases and cancers, highlighting its importance as a therapeutic target. CD40 monoclonal antibodies enable detailed analysis of immune cell interactions and signaling pathways. Researchers worldwide rely on CD40 monoclonal antibodies to explore immune regulation mechanisms and develop potential therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies for CD40 continue to support breakthrough discoveries in immunology research and therapeutic development.